Last reviewed · How we verify
NCT03286660: 3CRT
3 Minutes Chair Rise Test (3CRT) in Patients With COPD
NA trial testing Chair Rise Tests and short questionnaire in Evaluations in 127 participants. Completed in 24 July 2017.
24 July 2017
Quick facts
| Lead sponsor | University Hospital, Lille |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Design | sequential |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 127 |
| Start date | 8 December 2014 |
| Primary completion | 24 July 2017 |
| Estimated completion | 24 July 2017 |
| Sites | 2 locations across France |
Drugs / interventions tested
- Chair Rise Tests and short questionnaire
Conditions studied
- Evaluations — all drugs for Evaluations →
- Rehabilitation — all drugs for Rehabilitation →
- COPD — all drugs for COPD →
Sponsor
University Hospital, Lille
Who can join
Adults 40 to 85, any sex, with Evaluations or Rehabilitation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Improvement in the functional functioning and dyspnea of COPD patients after a rehabilitation program (RHB) is assessed by exercise tests and questionnaires difficult to replicate outside specialized centers. In order to monitor the eventual decline of patients in the course of their RHB management, Chair Rise Tests (3CRT-1CRT-5STS) and short questionnaires were developed (CAT-DIRECT). The goal of this prospective, multicenter, real-life study is to compare the change in several functional function tests and questionnaires of quality of life and dyspnea related to daily activities. In addition, MCIDs of the 3CRT and the DIRECT questionnaire (Disability Related to COPS Tool) were specified.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Minimal clinically important difference of 3-minute chair rise test and the DIRECT questionnaire after pulmonary rehabilitation in COPD patients.
Lévesque J, Antoniadis A, Li PZ, Herengt F, et al · · 2019 · cited 14× · PMID 30774324 · DOI 10.2147/copd.s187567
Verify or expand the search:
- PubMed search for NCT03286660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Lille trials
Trials by the same sponsor.
- NCT07528664 — Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking Duri · NA · not yet recruiting
- NCT07434739 — PAravertebral CaTheter Versus Epidural Analgesia in Totally Minimally Invasive Esophagectomies · NA · not yet recruiting
- NCT06958224 — Theranostic Approach by Early Multigene Sequencing in Advanced Poor Prognosis Cancers · NA · not yet recruiting
- NCT07408999 — Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer · NA · not yet recruiting
- NCT07492030 — Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03286660 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Lille
- Last refreshed: 18 September 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03286660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing